Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

785.50INR
3:50am EDT
Change (% chg)

Rs1.40 (+0.18%)
Prev Close
Rs784.10
Open
Rs785.00
Day's High
Rs796.50
Day's Low
Rs774.60
Volume
598,225
Avg. Vol
1,673,050
52-wk High
Rs891.50
52-wk Low
Rs582.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 10.53 March 27 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 12 11 10 9
(2) OUTPERFORM 17 14 14 12
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 1.78 1.79 1.81 1.83

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 2 42,117.60 45,003.20 39,232.00 39,331.00
Quarter Ending Mar-16 11 38,628.90 51,100.00 36,184.00 --
Year Ending Mar-16 21 141,862.00 206,860.00 135,099.00 --
Year Ending Mar-17 31 161,427.00 174,399.00 150,574.00 161,772.00
Year Ending Mar-18 30 183,826.00 201,560.00 168,602.00 180,856.00
Earnings (per share)
Quarter Ending Dec-16 2 10.53 11.53 9.53 8.65
Quarter Ending Mar-16 4 9.02 10.20 6.90 --
Year Ending Mar-16 22 34.52 37.60 31.80 --
Year Ending Mar-17 32 42.74 48.20 37.70 41.64
Year Ending Mar-18 31 51.02 59.00 41.20 49.71
LT Growth Rate (%) 2 26.09 27.40 24.78 23.15

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 38,628.90 36,747.00 1,881.95 4.87
Quarter Ending Dec-15 36,831.40 34,320.80 2,510.63 6.82
Quarter Ending Sep-15 34,736.10 32,801.10 1,935.02 5.57
Quarter Ending Jun-15 33,669.30 32,637.20 1,032.13 3.07
Quarter Ending Mar-15 32,554.60 31,439.70 1,114.94 3.42
Earnings (per share)
Quarter Ending Mar-16 9.02 9.63 0.61 6.79
Quarter Ending Dec-15 12.73 9.16 3.57 28.03
Quarter Ending Sep-15 12.43 7.73 4.70 37.81
Quarter Ending Jun-15 7.61 14.80 7.19 94.48
Quarter Ending Mar-15 7.22 6.92 0.30 4.21

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 42,117.60 42,117.60 41,826.90 41,645.40 39,331.00
Quarter Ending Mar-16 38,628.90 -- -- -- --
Year Ending Mar-16 141,862.00 -- -- -- --
Year Ending Mar-17 161,427.00 161,265.00 161,404.00 160,683.00 161,772.00
Year Ending Mar-18 183,826.00 183,462.00 183,450.00 181,667.00 180,856.00
Earnings (per share)
Quarter Ending Dec-16 10.53 10.53 9.53 9.21 8.65
Quarter Ending Mar-16 9.02 -- -- -- --
Year Ending Mar-16 34.52 -- -- -- --
Year Ending Mar-17 42.74 42.76 42.93 42.92 41.64
Year Ending Mar-18 51.02 50.98 51.04 50.76 49.71

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 0 0 1 0
Quarter Ending Mar-16 -- -- -- --
Year Ending Mar-16 -- -- -- --
Year Ending Mar-17 0 0 3 1
Year Ending Mar-18 0 0 2 0
Earnings
Quarter Ending Dec-16 0 0 0 0
Quarter Ending Mar-16 -- -- -- --
Year Ending Mar-16 -- -- -- --
Year Ending Mar-17 0 0 1 3
Year Ending Mar-18 0 0 1 1

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$10.00
Provider : Motilal Oswal Securities Ltd.
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.